Literature DB >> 3164675

The infiltrated radiopharmaceutical injection: dosimetric considerations.

F P Castronovo1, K A McKusick, H W Strauss.   

Abstract

A small proportion of radiopharmaceutical administrations are extravasted from the injection site to the surrounding tissue. Of interest is the resulting absorbed dose. This investigation was undertaken to determine the biologic behavior and subsequent dosimetry of selected radiopharmaceutical infiltrations using a rat model. Subcutaneous injection of 99mTc-microspheres, 99mTc-MDP, 67Ga-citrate, and 201Tl-chloride were studied. Three adult male Sprague-Dawley rats were injected subcutaneously at three separate sites on the shaven backs of the animals for each agent studied (i.e., nine sites per agent). The rats were imaged and the resulting data were analyzed by computer immediately after injection and at various intervals up to 5-6 h, and again at 24 h. Particulate subcutaneous 99mTc-microspheres exhibit essentially no diffusion of tracer from the injection site, whereas non particulates showed a biexponential release pattern. Radiation burdens in rad/mCi (mGy/MBq) due to an infiltrate volume uniformally distributed over a 5 g mass for 99mTc-microspheres, 99mTc-MDP, 67Ga-citrate and 201Tl-chloride were 59.4(16.0), 13.6(3.7), 32.9(8.9) and 92.2(24.9), respectively. The radiobiological risk associated with these radiation burdens are below that needed to produce severe skin reactions when distributed within a 5 g mass.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3164675     DOI: 10.1007/bf00253448

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  6 in total

1.  Skin cancer: correlation of field size and cancerocidal dose in Roentgen treatment.

Authors:  K D ALLEN; J H FREED
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1956-03

2.  External therapeutic use of radioactive phosphorus; erythema studies.

Authors:  B V A LOW-BEER
Journal:  Radiology       Date:  1946-09       Impact factor: 11.105

3.  Accidental skin ulcerations from radioisotopes; recognition, prevention and treatment.

Authors:  H S PATTON; R G MILLAR
Journal:  J Am Med Assoc       Date:  1950-06-10

4.  Dosimetric consequences of interstitial extravasation following i.v. administration of a radiopharmaceutical.

Authors:  B Shapiro; M Pillay; P H Cox
Journal:  Eur J Nucl Med       Date:  1987

5.  Technetium-99m stannous phytate as an imaging agent for lymph nodes.

Authors:  A Alavi; M M Staum; B F Shesol; P H Bloch
Journal:  J Nucl Med       Date:  1978-04       Impact factor: 10.057

6.  Clinical comparison of two radiocolloids for internal mammary lymphoscintigraphy.

Authors:  W D Kaplan; C W Piez; R S Gelman; S M Laffin; E M Rosenbaum; C A Jennings; C A McCormick; J R Harris; I C Henderson; H L Atkins
Journal:  J Nucl Med       Date:  1985-12       Impact factor: 10.057

  6 in total
  3 in total

1.  EANM-EORTC general recommendations for sentinel node diagnostics in melanoma.

Authors:  Annette H Chakera; Birger Hesse; Zeynep Burak; James R Ballinger; Allan Britten; Corrado Caracò; Alistair J Cochran; Martin G Cook; Krzysztof T Drzewiecki; Richard Essner; Einat Even-Sapir; Alexander M M Eggermont; Tanja Gmeiner Stopar; Christian Ingvar; Martin C Mihm; Stanley W McCarthy; Nicola Mozzillo; Omgo E Nieweg; Richard A Scolyer; Hans Starz; John F Thompson; Giuseppe Trifirò; Giuseppe Viale; Sergi Vidal-Sicart; Roger Uren; Wendy Waddington; Arturo Chiti; Alain Spatz; Alessandro Testori
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-10       Impact factor: 9.236

2.  Practical Tools for Patient-specific Characterization and Dosimetry of Radiopharmaceutical Extravasation.

Authors:  Sean Wilson; Dustin Osborne; Misty Long; Josh Knowland; Darrell R Fisher
Journal:  Health Phys       Date:  2022-07-15       Impact factor: 2.922

3.  Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease.

Authors:  Andrew M Smith; Farooq Z Rahman; Bu'Hussain Hayee; Simon J Graham; Daniel J B Marks; Gavin W Sewell; Christine D Palmer; Jonathan Wilde; Brian M J Foxwell; Israel S Gloger; Trevor Sweeting; Mark Marsh; Ann P Walker; Stuart L Bloom; Anthony W Segal
Journal:  J Exp Med       Date:  2009-08-03       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.